Patients present for a splenectomy for a variety of reasons. Anaesthetists need to be aware of the associated implications of concurrent disease in planning appropriate perioperative care. This article will summarize the basic science and perioperative considerations for splenectomy.
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The arterial supply to the spleen is via the tortuous splenic artery (one of the three branches of the coeliac axis) and the short gastric arteries (branches of the left gastroepiploic artery) supplying the upper pole of the spleen. The splenic artery divides at the hilum, providing a segmental blood supply.
Posterior to the neck of the pancreas, the splenic vein joins the superior mesenteric vein to form the portal vein. 2 
Functions
The spleen has two main functions: as a secondary lymphoid organ of the immune system and a housekeeping role destroying senescent erythrocytes and the phagocytosis of particulate material in the blood. 3 The bone marrow and the thymus are the primary lymphoid organs, controlling the production and maturation of lymphocytes. The spleen '. . . processes and presents antigens, ultimately leading to successful elimination of pathogens and induction of adaptive immunity. . .'.
• Overwhelming post-splenectomy sepsis is an often fast and catastrophic complication of splenectomy with mortality rates of 40-70%.
• For patients presenting for splenectomy, a multidisciplinary team is essential for the best perioperative outcome.
• Anaesthetists play a key role in the management and coordination of the splenic trauma patient, and should have knowledge of all treatment modalities and organizational availability and capability.
• Splenic artery aneurysm is a rare, but important differential diagnosis in the shocked pregnant patient with abdominal pain.
which may occur anywhere in the abdomen, but are usually situated near the splenic hilum. If they remain after splenectomy, they may result in persistence of symptoms.
Splenic artery aneurysm
Splenic artery aneurysms (SAAs) are defined by a pathological dilatation of the splenic artery to >1 cm in diameter. SAAs are the third most common abdominal aneurysm after aortic and iliac artery aneurysms. 5 The prevalence in the general population is thought to be low at $0.1-0.2%, although an autopsy study in patients over 60 years of age, looking specifically at the spleen, found a prevalence as high as 10.4%. The true prevalence remains unknown because 95% of individuals remain asymptomatic. Generally, SAAs manifest in one of three ways: (i) as an incidental finding at angiography, laparotomy, or postmortem, (ii) abdominal pain, and (iii) after rupture with hypotension and a sudden collapse (2-10% of patients).
There is a strong association between pregnancy and SAA formation, especially in the multiparous woman; and $95% of SAA ruptures occur during pregnancy, most commonly during the third trimester. Though the rupture of an SAA during pregnancy is a rare event, it carries a high risk of maternal and fetal mortality. The mortality of SAA rupture in the general population is 25%. In a pregnant woman, this mortality rate increases to 75% with a fetal mortality rate of 95%. 5 If a woman has an existing SAA, the risk of it rupturing during pregnancy is 20-50%. Although SAA rupture is rare, it is an important differential diagnosis to consider, especially in the context of abdominal pain or shock in pregnancy or labour, particularly as SAA rupture in pregnancy is difficult to diagnose because its symptoms mimic other obstetric and surgical emergencies. Approximately 70% of cases of SAA rupture during pregnancy are misdiagnosed as uterine rupture, placental abruption, amniotic fluid embolism, or perforated peptic ulcer.
With the increasing use of high-resolution imaging, the number of incidentally detected SAAs will inevitably rise. In the non-pregnant population, SAAs that are larger in size, commonly > 2 cm, or grow during the interval observation period are appropriate for treatment. However, it has been recently shown that up to half of splenic artery aneurysms that rupture during pregnancy are <2 cm in diameter. Owing to the high fetal and maternal mortality associated with rupture during pregnancy, some experts recommend that all SAAs, regardless of size, should be treated during pregnancy. Evidence suggests that endovascular ablation is a safe and effective treatment of non-ruptured SAAs. 5 However, a ruptured SAA remains a lifethreatening entity, and emergency laparotomy by general and or vascular consultants is recommended.
Splenomegaly and hypersplenism
If splenomegaly is accompanied by functional disturbance (pancytopenia) then this is termed hypersplenism; each may be found separately and not necessarily coexist. There is no agreement on categorizing the degrees of splenomegaly. Splenic size has been characterized in terms of length or weight and has consequences for the surgical management of disease. Normal spleens are <12 cm in longest craniocaudal length, moderately enlarged spleens are 12-20 cm, and severely enlarged spleens are >20 cm. 6 In terms of weight, spleens weighing 500-1000 g are splenomegalic and >1000 g are 'massive'. There are numerous causes of splenomegaly, which may also result in hypersplenism (see Table 2 ). In the developed world, infectious mononucleosis remains the commonest cause of splenomegaly, followed by infiltration from haematological malignancy, and portal hypertension secondary to liver disease.
Hyposplenism and overwhelming post-splenectomy infection syndrome 'Functional hyposplenism' was a term first used by Pearson and colleagues in 1969, 7 who noticed that children with sickle cell disease had the same clinical findings as splenectomized patients. Conditions associated with functional hyposplenism include alcoholic liver disease, sickle-cell anaemia, bone marrow transplantation, coeliac disease, and inflammatory bowel disease. 3 Removal of senescent erythrocytes is defective in hyposplenism, causing pathological erythrocyte appearances on a blood film: acanthocytes (spikey appearance), target cells (central staining resembling a 'bullseye' target), surface pitting ('poked'), and Howell-Jolly bodies (spots of basophilic nuclear remnants). As there is no reliable way of assessing splenic function, the presence of these abnormal erythrocytes is taken as a surrogate marker of hyposplenism; however, their absence does not exclude it. Functional hyposplenism is characterized by an increased susceptibility to infection by encapsulated microorganisms, with potentially rapid progression similar to that seen in the syndrome of life-threatening overwhelming postsplenectomy infection (OPSI). OPSI remains a rare condition (estimated incidence of 0.23-0.42% per year, with a lifetime risk of 5%); 8 the highest risk is among those who have had a splenectomy for haematological malignancy and children (particularly those under two). It carries a high mortality, with risk highest in the first 3 yr after splenectomy, declining thereafter, although lifelong risk remains. It is owing to the recognition of this syndrome that we attempt to preserve the spleen if at all possible. OPSI has a catastrophically rapid onset; it is characterized by the following findings:
• Massive bacteraemia; blood cultures can show the number of bacterial colonies up to 10 000 times higher than the colony count in common septicaemia. 8 • No obvious primary source of infection.
• Short, vague prodromal phase (e.g. a slight upper respiratory tract infection).
• Septic shock accompanied by multi-organ dysfunction and disseminated intravascular coagulation.
• Waterhouse-Friedrichsen syndrome: bilateral adrenal haemorrhage.
Streptococcus
pneumoniae, Neisseria meningitides and Haemophilus influenza are the most common causative microorganisms. 9 Prompt recognition of patients at risk for OPSI, followed by early intensive care sepsis treatment strategies, including (for example): antibiotics, vasopressors, goal-directed i.v. fluids, steroids, heparin, red blood cells, platelets, cryoprecipitates, and fresh frozen plasma are essential to limit morbidity and mortality. However, owing to the fulminant nature of this condition, even these aggressive strategies may fail to alter the clinical course, and a high mortality rate (40-70%) still remains. Prevention has become key. Important preventative measures are patient and clinician education, vaccination schedules, and the avoidance of total splenectomy by an individualized approach to traumatic injuries and underlying pathology.
Antibiotics in asplenic patients
There are no agreed rules regarding prophylactic antibiotics in asplenic patients. Prophylactic penicillin has been shown to confer protection against pneumococcal infection in asplenic children with sickle cell disease; however, no studies have been undertaken in splenectomized adults.
Due to the lifelong risk of OPSI, lifelong prophylactic antibiotics should be offered to those at high risk of pneumococcal infection:
• Aged <16 yr or >50 yr • Inadequate serological response to pneumococcal vaccine.
• With a history of previous invasive pneumococcal disease, or after an episode of post-splenectomy sepsis.
• Impaired immune function (malignancy) and in whom a splenectomy was carried out for haematological malignancy.
Counselling regarding the risks and benefits of lifelong antibiotics should be offered to patients not at high risk of infection, and in these patients, it may be appropriate to discontinue. 8, 10, 11 Patient education is of vital importance, and asplenic patients should be given a 5-day supply of stand-by antibiotics to be stored in their household refrigerator, with advice cards on when to use them.
Vaccinations
A vaccination schedule should include cover for the commonly implicated microorganisms (pneumococcal, Hib, meningococcal, influenza; all can be given together if necessary). 8 Ideally, these should be administered at least 2 weeks before scheduled splenectomy as the immune response to vaccines is thought to be better with an intact spleen. In emergency splenectomy patients, a better antibody response occurs if vaccination is delayed for 14 days after surgery to minimize the immunosuppressive effects of surgery. Careful coordination with primary care is necessary upon discharge to ensure all vaccinations are given. In hyposplenic patients receiving immunosuppressive therapies (steroids or chemotherapy), it is recommended that vaccination is given at least 2 weeks before immunosuppressive therapy and/or delayed for 3 months after the therapy has been completed. Despite receiving a vaccination schedule, clinical vigilance for vaccine failures should exist: strains may not be included in the vaccine, or there may have been a poor vaccine antibody response because of the splenectomy or underlying disease. Revaccination should occur every 5 yr.
Splenic infarction-the imitator of sepsis
Splenic infarction may occur in the whole spleen or via occlusion of one of the segmental secondary arterial branches to the spleen, which would result in a wedge-shaped infarct. Collateral flow from the short gastric arteries often preserves some or all of the spleen. There are numerous causes of splenic infarction ( Table 3 ). The majority are attributable to infiltrative haematological diseases congesting the splenic circulation with pathological cells, or thromboembolic conditions which obstruct larger vessels. 12 The clinical spectrum of splenic infarction ranges from asymptomatic infarction in approximately one-third (thus discovered incidentally on radiological studies or during surgery for another indication) to haemorrhagic shock (from subcapsular haemorrhage or rupture into the peritoneal cavity). The commonest presenting symptom, however, is left-upperquadrant abdominal pain ($70%), with signs resembling sepsis (fever, rigors, nausea, and vomiting), pleuritic chest pain, and left shoulder pain (Kehr sign). 12 Computed tomography (CT) with contrast is the best diagnostic modality. Prognosis is variable, depending upon the underlying disease state. If infarction renders the individual hyposplenic, patients should be counselled as to the risk of OPSI. Splenic infarction alone is not an indication for surgery; however, conservative management will include surveillance in light of the The spleen complications of infarction: haemorrhage, rupture, abscess, or persistent pseudocyst where surgery may be indicated.
Splenectomy
Splenectomy is primarily performed for trauma and refractory haematological disease (e.g. idiopathic thrombocytopenia purpura, hereditary spherocytosis, thalassemia, Hodgkin disease, leukaemias and myeloproliferative disease, Felty syndrome). Splenectomy for haematological disease is managed predominantly by a laparoscopic technique. The commonest exception is massive splenomegaly, 13 for the obvious reasons of limitation in instrumentation and visualization.
Preoperative planning
A basic understanding of the underlying disease state is necessary to provide an individualized perioperative management plan. In addition to routine preoperative assessment for major surgery, close liaison with a haematologist is necessary; these patients are often anaemic (spherocytosis, thalassemia, sickle cell disease) and thrombocytopenic (ITP), they may have systemic complications of previous chemotherapy, chronic disease states and malignancy, they may require irradiated or human leucocyte antigen (HLA) matched products, immunoglobulins, steroids, or preoperative splenic artery embolization (refractory thrombocytopenia in ITP). Involvement of a multidisciplinary team (haematologist, oncologist, interventional radiologist, surgeon, anaesthetist, and intensivist) is essential. In the case of ITP, there have been numerous case reports and expert reviews on what constitutes a safe platelet count for laparoscopic splenectomy [all published data reviewed describe normal prothrombin time (PT) and activated partial thromboplastin times (APTT)] (implications for neuraxial blockade are described later); predictably, those patients undergoing laparoscopic splenectomy with very low platelet counts (<20Â10 9 litre À1 ) received more blood transfusions, suffered more complications, and had a much longer hospital stay than patients with platelet counts of 20-50Â10 9 litre À 1 or higher. The evidence agrees that the strongest predictor for transfusion, morbidity, and mortality in this group of patients is the platelet count. 14 Every effort should be made to liaise with haematologists to elevate platelet counts to >20Â10 9 litre À 1 before surgery.
14 If it is necessary to increase the platelet count in ITP patients before surgery, i.v. immunoglobulins or steroids are used. Platelet transfusion should be avoided until after surgery (or if required during surgery) after 'inflow' vascular isolation has occurred 15 to avoid sequestration in the spleen. These patients may be chronically dependent on steroids and adrenal insufficiency, and perioperative steroid supplementation should be considered.
Surgical approach and general intraoperative measures
The surgical approach depends on splenic size, indication, and surgical preference. In emergency or trauma, open surgery in the supine position via an upper midline incision is preferable as it affords excellent exposure, rapid access, and evaluation of other structures. In most patients undergoing open splenectomy for haematological disorders, a left subcostal incision is used.
Positioning for laparoscopic splenectomy is supine or lateral. The original approach for laparoscopic splenectomy was anterior, with the viscera retracted away from the left upper quadrant by a steep reverse Trendelenberg position. The anterior approach should also be considered when simultaneous procedures may be needed (e.g. cholecystectomy) or with larger spleens, which may require an extraction strategy (e.g. a Pfannenstiel incision). However, there are disadvantages to the anterior approach: the spleen must be lifted off its posterior attachments and as splenic size increases, this becomes more challenging, especially in obese patients. Adapting positioning from laparoscopic adrenalectomy, the lateral approach has developed, with the patient in lateral decubitus; many authors advocate this approach as the weight of the spleen acts as its own retractor, falling away from the posterior and lateral attachments. 6 As per standard NICE guidance, local antibiotic formulary for antibiotic prophylaxis for major abdominal surgery should be adhered to, and a vaccination schedule organized before surgery. After induction of general anaesthesia, the patient is intubated and an orogastric tube inserted to ensure deflation of the stomach. When ventilating a patient in the lateral position, a ventilation-perfusion mismatch occurs, with perfusion greatest in the dependent lung and ventilation greatest in the nondependent lung; this is usually well tolerated, but may lead to atelectasis and hypoxia in susceptible patients aggravated by the reduction in functional residual capacity caused by the pneumoperitoneum.
Vacuum beanbags aid positioning in the lateral decubitus position. The radial, saphenous, and the common peroneal nerves are susceptible to injury in this position. The forearm can be supported with specially designed rests or the upper arm can hug a pillow; meticulous attention should be given to pressure points, with pillows between the legs and arms. This position is associated with the greatest number of ocular complications, so confirm the eyes are taped shut and that pressure is not being applied to the globe. Ensure the ear has not folded during positioning.
In the case of elective splenectomy, one of the first steps is transection of the ligamentous attachments, which contain The spleen numerous blood vessels. Pathological spleens often have more attachments, and may contain aberrant vessels that could cause further blood loss. Then the splenic artery and veins are identified, dissected, and ligated. To avoid injury to the pancreas, this dissection is carried out at the hilum in close proximity to the spleen. There is potential for massive blood loss (aggravated by associated disease and disease-related coagulopathies), and blood loss can be highly variable. Predictably, the data show that splenomegaly is the main determinant for operative blood loss, and blood loss is the main factor correlating with morbidity and mortality. Pneumoperitoneum and the reverse Trendelenburg position may exacerbate haemodynamic instability, with deleterious effects on preload and cardiac output. Therefore, we advocate a minimum of one large-bore peripheral cannula and a low threshold for insertion of invasive and cardiac output monitoring, allowing earlier detection and management of fluctuations in haemodynamic status. Appropriate fluid management is particularly important in sickle cell anaemia and spherocytosis, where avoidance of crises through appropriate filling, prevention of hypoxia and acidosis, and temperature regulation are paramount.
Neuraxial block and venous thromboembolism
Haematological issues (pre-, peri-and postoperative) may preclude central neuraxial block owing to the risk of epidural haematoma. In haemato-oncology patients, there are insufficient data on a safe platelet number to guide neuraxial catheter placement or removal (as we use number as a surrogate of function); however, evidence agrees that the cut-off be set at counts >100Â10 9 litre
À1
. 15 There is huge variability in preoperative platelet counts and postoperative platelet profiles, meaning that attempts to predict postoperative platelet behaviour are impossible (with authors reporting both postoperative thrombocytopenia and thrombocytosis). 15 In the thrombocytopenic parturient, high circulating levels of fibrinogen and clotting factors, reduced fibrinolysis, and largely normal platelet function allow neuraxial block at lower platelet thresholds; this is of course not seen in haemato-oncology patients, who have intrinsic platelet defects with no compensatory increase in clotting factors, explaining the more conservative cut-off of 100Â10 9 litre À1 .
15
Patients having splenectomies for myeloproliferative disorders deserve special mention here, as the incidence of postoperative portal vein thrombosis is high (40%), especially in those with massive splenomegaly. Therefore, in this cohort of patients, the risk of needing postoperative anticoagulation or emergency thrombolysis may further preclude the placement of an epidural catheter. If postoperative emergency thrombolysis is required in a patient with an epidural catheter in situ, it should be done under close monitoring, weighing the risks and benefits.
The maximal nadir of fibrinogen and plasminogen after thrombolytic therapy is at 5 h, and they are still depressed at 27 h. 16 The Association of Anaesthetists of Great Britain and Ireland advise waiting 10 days after cessation of thrombolysis before performing a neuraxial block, and 10 days after block (or epidural catheter removal) before thrombolysis can be administered. 17 Therefore, if an epidural catheter was in situ and emergency thrombolysis was required, removing the epidural catheter before thrombolysis administration would significantly delay (by 10 days) thrombolysis, with the risk of clot extension. Hence, thrombolysis whilst keeping the epidural catheter in situ is often the only choice; with cessation of the epidural local anaesthetic infusion, close neurological monitoring, and monitoring of fibrinogen concentrations to help time catheter removal, possibly with fresh frozen plasma cover. 16 The risk of both short-and long-term venous thromboembolism (VTE) is increased in post-splenectomy patients. The mechanism of this increased VTE risk is multifactorial and relates to underlying pathology; in brief, we know that surgery, blood transfusions, immobility, and trauma are associated with VTE risk. Patients having a splenectomy have the additional risks of: malignancy, haematological disorders, and the resulting thrombocytosis and hypercoagulability from increased numbers of damaged circulating erythrocytes post-splenectomy. There is also evidence to suggest that clinicians are more concerned with postoperative bleeding risk in this cohort of patients, and thus VTE prophylaxis is delayed. There is scarce evidence at present to guide when to initiate peri-/postoperative pharmacological VTE prophylaxis, and how long to continue this for, in splenectomy patients. Thus, clinicians should have an awareness of this increased risk, and an individualized approach with adherence to the current general NICE and ACCP (the American College of Chest Physicians) VTE prophylaxis guidelines.
Partial splenectomy, autotransplantation, and iatrogenic splenic injury
The recognition of OPSI has generated alternatives to traditional splenectomy: autotransplantation of the removed spleen and partial splenectomy.
Autotransplantation was introduced based on the observation of splenosis: the persisting presence of small parts of viable splenic tissue in the abdomen after splenectomy for trauma. Studies have been performed leaving spleen tissue deliberately in the abdomen after splenectomy, mostly in an omental pouch. 18 Although there have been numerous positive studies involving autotransplantation, partial splenectomy is preferable because it is associated with higher antibody titres after immunization, better pneumococcal splenic uptake, and improved survival rates. 19 This is understandable given the disrupted vascular and microanatomical architecture of the splenic fragments in autotransplantation. Certain conditions are appropriate for a subtotal or partial splenectomy; these include diagnostic partial splenectomy for idiopathic splenomegaly, when iatrogenic injury to the spleen has occurred, splenic infarct, splenic cysts, benign tumours, Gaucher disease, and hereditary spherocytosis (HS). The haemolytic complications of HS, such as anaemia and gallstones, can be greatly reduced by a partial splenectomy whilst preserving the immune role of the spleen with a balance between not achieving the total abrogation of symptoms that a total splenectomy affords, but avoiding the lifelong infective sequelae of asplenia.
Generally, 10-30% of splenic parenchyma is preserved, splenic regrowth does not necessarily occur; but later completion splenectomy may be indicated (10% of individuals at 5 yr, increasing to 30% at 10 yr). 19 Partial splenectomy can be performed as a laparoscopic technique. Pneumococcal vaccinations are given as for total splenectomy and postoperative penicillin prophylaxis continued for $1 yr, or discontinued when normal phagocytic function returns. Nearly half of all incidental splenectomies from iatrogenic splenic injury occur during colorectal surgery. Open surgery carries a higher risk from capsular tears and lacerations owing to misplaced traction and tension on the spleen. If injury The spleen occurs, organ-preserving procedures are recommended. 20 Splenorrhaphy can manage small lacerations or other injuries that are localized to one pole of the spleen, or partial splenectomy can be performed as described earlier.
Managing the asplenic patient for subsequent operations
If a patient with asplenia or functional hyposplenism presents for subsequent elective or emergency surgery, it is necessary to ascertain their vaccination history. Hyposplenic patients fail to mount a normal physiological response to microbial insult, so a low threshold for investigation and treatment if any evidence of infection should exist. A multidisciplinary approach including haematology and microbiology will help to guide this.
Traumatic splenic injury
Splenic injury is commonly associated with blunt abdominal trauma (up to 45% of abdominal trauma patients have a splenic injury); however, rupture can also occur after medical procedures, in malignancy, and with infection. The clinical signs affiliated with splenic injury are extremely unreliable; patients can present with few symptoms or signs (in the case of a contained rupture), with or without shock; they may have diffuse abdominal pain or more localized left upper quadrant pain, left shoulder tip pain, or pleuritic-type left-sided pain. Splenic trauma or rupture may require urgent operative management.
Non-operative strategies were proposed in the paediatric population in the 1960s, with the goal of preserving the spleen and it is vital immunological role. With improvement and availability of contrast-enhanced CT scans, non-operative management has now become a mainstay in the management of haemodynamically stable patients. For minor splenic trauma (grades I and II; see Table 4) , 11 non-operative strategies have the advantage of avoiding surgery, total splenectomy, and the risks of OPSI; are cheaper and have a lower morbidity with fewer intra-abdominal complications, reduced blood transfusions, and a decreased mortality. 11 The evidence for non-operative management for higher grades of splenic injury (grades IV and V) is more difficult to interpret, 21 because of differing hospital expertise, inappropriate comparison groups, and inclusion of patients with concurrent injuries, meaning that comparing outcomes of a non-operative paradigm vs operative one in severe splenic trauma is not reliable. 21 Therefore, it remains that in patients presenting with haemodynamic instability and peritonitis, whatever the grade of injury, emergency surgery is still warranted, and conversely, that in the haemodynamically stable patient, irrespective of patient age, the presence of associated injuries, or the grade of injury (factors thought previously to preclude a conservative strategy) a trial of non-operative management may be considered. 21, 22 However, this nonoperative paradigm should only be considered in an environment that has capabilities for serial clinical evaluations and monitoring and an operating room and surgeon available for urgent laparotomy. The frequency of haemoglobin measurements, blood transfusion, angiographic or operative triggers, intensity and duration of monitoring, and duration of a hospital stay have not been fully described or evaluated. The evidence suggests pharmacological VTE prophylaxis in patients with isolated blunt splenic injuries is safe, although the optimal timing of its safe initiation has yet to be determined. 22 After non-operative management (with or without splenic angioembolization), immunization and antibiotic prophylaxis are not routinely necessary as evidence suggests that immune function is reasonably well preserved.
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Angioembolization
Adjunctive therapies, such as angiography with embolization in the interventional radiology suite, are increasingly important evolving tools in the management of splenic injuries, particularly with regard to the higher grades of injury. 11, 22 Embolization methods include chemical agents (thrombin, gelfoam, sclerosant chemicals) or mechanical (metal coils, embolization particles). Despite the large numbers of studies on this technique, controversy still exists, with varying outcomes and recommendations. 11 Complications of this technique include splenic infarction, cyst or abscess formation, contrast-induced nephropathy and bleeding (occurring in 14-29% of patients).
Minor complications, such as coil migration, left pleural effusion, and pyrexia, can occur in 34-62% of patients. 23 
Conclusion
This article has endeavoured to highlight the importance of splenic pathology in a variety of clinical situations. The authors hope that the spleen will now receive its deserved consideration in, for example, the pregnant patient with shock and or abdominal pain (SAA), in the patient with embolic risks presenting with abdominal pain (splenic infarction), in the septic patient (is the patient hyposplenic or asplenic, is this OPSI?), and in the commonly encountered trauma patient presenting with shock, abdominal pain or both. The spleen is no longer a vestigial, sacrificial organ; all attempts wherever possible should be made to preserve its function. As anaesthetists we are present at trauma calls, the CT scanner, interventional radiology, theatres, and intensive care; we therefore have a fundamental role in the whole splenic trauma patient journey, including diagnosis, resuscitation, operative, and postoperative management. Our skills in the recognition, The spleen re-evaluation, and treatment of the critically ill patient are important here, but also we should have a pragmatic knowledge of the limitations and capabilities of the environment in which we work; for example, should this unstable patient go to the CT scanner or straight to the operating theatre? Should we transfer the patient to another hospital which has interventional radiology capabilities to embolize this splenic injury, or observe on the surgical ward, High Dependency Unit (HDU) or Intensive Care Unit (ICU) or go to theatre for an exploratory laparotomy? Thus our skills are not only essential in the clinical management of the acutely unwell patient, but also in communication with the whole multidisciplinary team to ensure the most timely and safest management of these patients.
Declaration of interest
None declared.
MCQs
The associated MCQs (to support CME/CPD activity) can be accessed at https://access.oxfordjournals.org by subscribers to BJA Education.
